At close: December 13 at 11:02:55 AM GMT+11
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
-3,179.9550
-3,179.9550
-1,665.2070
-3,099.2050
-1,423.9600
Investing Cash Flow
--
--
-53.1240
-202.2900
-4.3570
Financing Cash Flow
7,216.1410
7,216.1410
-78.2230
4,693.4830
-82.5030
End Cash Position
5,504.3960
5,504.3960
1,468.2100
3,264.7640
1,872.7760
Interest Paid Supplemental Data
11.4790
11.4790
1.9920
6.7920
5.9250
Capital Expenditure
--
--
-53.1240
-202.8210
-5.1500
Issuance of Capital Stock
8,003.5940
8,003.5940
1.9890
5,060.0010
--
Repurchase of Capital Stock
-716.5290
-716.5290
--
-294.2000
--
Free Cash Flow
-3,179.9550
-3,179.9550
-1,718.3310
-3,302.0260
-1,429.1100
12/31/2020 - 8/31/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIT.AX Biotron Limited
0.0170
-5.56%
BTC.AX BTC Health Limited
0.0660
-1.49%
ANR.AX Anatara Lifesciences Ltd
0.0470
+2.17%
1AI.AX Algorae Pharmaceuticals Limited
0.0080
0.00%
CHM.AX Chimeric Therapeutics Limited
0.0060
0.00%
ATX.AX Amplia Therapeutics Limited
0.0860
-1.15%
1AD.AX AdAlta Limited
0.0170
-5.56%
CMB.AX Cambium Bio Limited
0.4400
-18.52%
AGN.AX Argenica Therapeutics Limited
0.6850
-0.72%
NOX.AX Noxopharm Limited
0.1000
0.00%